Literature DB >> 7883862

Cystic fibrosis-related diabetes is associated with HLA DQB1 alleles encoding Asp-57- molecules.

M Carrington1, L J Krueger, D S Holsclaw, M C Iannuzzi, M Dean, D Mann.   

Abstract

The incidence of insulin-dependent diabetes in individuals with cystic fibrosis is nearly 100 times greater than in the general population. In the latter group, strong associations with specific HLA DQA1 and DQB1 alleles have been observed. To determine if a similar distribution of alleles occurs in cystic fibrosis patients with diabetes, a cohort of these individuals was typed for DQA1 and DQB1 alleles. HLA DQB1*0201 (Asp57-) was more frequent in diabetics compared to controls (40.4 vs 28%), while the frequency of alleles encoding Asp57+ molecules was lower in diabetics relative to both the cystic fibrosis-only controls (P = 0.025) and the general population (P = 0.008). The presence of at least one protective DQA1-DQB1 heterodimer (i.e., Arg52- and Asp57+, respectively) in cis or trans was significantly lower in the diabetics than in either of the control groups. Thus, the HLA alleles known to be associated with insulin-dependent diabetes mellitus in the general population are also found in diabetics with cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7883862     DOI: 10.1007/bf01546319

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  33 in total

1.  Two patients with cystic fibrosis, nonsense mutations in each cystic fibrosis gene, and mild pulmonary disease.

Authors:  G R Cutting; L M Kasch; B J Rosenstein; L C Tsui; H H Kazazian; S E Antonarakis
Journal:  N Engl J Med       Date:  1990-12-13       Impact factor: 91.245

Review 2.  Cystic fibrosis and diabetes mellitus: interactive or idiopathic?

Authors:  L J Krueger; A Lerner; S M Katz; R Mack; D S Holsclaw; E Lebenthal
Journal:  J Pediatr Gastroenterol Nutr       Date:  1991-08       Impact factor: 2.839

3.  Risks of alternate-day prednisone in patients with cystic fibrosis.

Authors:  B J Rosenstein; H Eigen
Journal:  Pediatrics       Date:  1991-02       Impact factor: 7.124

4.  HLA frequencies in patients with cystic fibrosis.

Authors:  J Säfwenberg; H Kollberg; J B Lindblom
Journal:  Tissue Antigens       Date:  1977-10

5.  Inheritance of insulin-dependent diabetes.

Authors:  W Klitz
Journal:  Nature       Date:  1988-06-02       Impact factor: 49.962

Review 6.  HLA studies in diabetes mellitus: a review.

Authors:  J Nerup
Journal:  Adv Metab Disord       Date:  1978

7.  Genotype analysis in cystic fibrosis in relation to the occurrence of diabetes mellitus.

Authors:  I Hamdi; S J Payne; D E Barton; R McMahon; M Green; J M Shneerson; C N Hales
Journal:  Clin Genet       Date:  1993-04       Impact factor: 4.438

8.  Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus.

Authors:  J M Baisch; T Weeks; R Giles; M Hoover; P Stastny; J D Capra
Journal:  N Engl J Med       Date:  1990-06-28       Impact factor: 91.245

9.  Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study.

Authors:  P A Morel; J S Dorman; J A Todd; H O McDevitt; M Trucco
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

10.  Age-related alterations of immunoreactive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency.

Authors:  P R Durie; G G Forstner; K J Gaskin; D J Moore; G J Cleghorn; S S Wong; M L Corey
Journal:  Pediatr Res       Date:  1986-03       Impact factor: 3.756

View more
  3 in total

Review 1.  Update on gene modifiers in cystic fibrosis.

Authors:  Joseph M Collaco; Garry R Cutting
Journal:  Curr Opin Pulm Med       Date:  2008-11       Impact factor: 3.155

Review 2.  Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review.

Authors:  Antoinette Moran; Dorothy Becker; Samuel J Casella; Peter A Gottlieb; M Sue Kirkman; Bruce C Marshall; Bonnie Slovis
Journal:  Diabetes Care       Date:  2010-12       Impact factor: 19.112

3.  The ΔF508 Mutation in the Cystic Fibrosis Transmembrane Conductance Regulator Is Associated With Progressive Insulin Resistance and Decreased Functional β-Cell Mass in Mice.

Authors:  Ghislaine Fontés; Julien Ghislain; Isma Benterki; Bader Zarrouki; Dominique Trudel; Yves Berthiaume; Vincent Poitout
Journal:  Diabetes       Date:  2015-08-17       Impact factor: 9.461

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.